Aurovisc Lubricant Hypromellose 2208 (15000 Mpa.s) Solution/drops
NDC Package 16030-302-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Aurovisc Lubricant Hypromellose 2208 (15000 Mpa.s) Solution/drops is a medication used as Lubricant. Marketed by Aurolab, this product is identified by NDC 16030-302 and is authorized under FDA application part349.

Identification & Billing

NDC Package Code
16030-302-02
Package Description
2 mL in 1 SYRINGE, GLASS
Product Code
16030-302
11-Digit Billing Format
16030030202
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Aurovisc Lubricant Hypromellose 2208 (15000 Mpa.s) Solution/drops
Dosage Form
-
Usage Information
This product is used as Lubricant

Regulatory & Marketing

Labeler Name
Aurolab
FDA Application #
part349
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
09-26-2022
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 16030-302-02 identifies a specific commercial package of 2 ml in 1 syringe, glass of Aurovisc Lubricant Hypromellose 2208 (15000 Mpa.s) Solution/drops, labeled by Aurolab. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aurolab on September 26, 2022. The current certification is valid through December 31, 2024.

How is this Aurolab product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 16030030202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
16030-302-02
11-Digit CMS (5-4-2)
16030-0302-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.